Digital Country focus: Hungary carves out a niche in digital pharma AI simulated cell company Turbine is just one of many digital drug discovery firms on the rise in Hungary.
Views & Analysis The Simulated Cell: can a digital model aid cancer drug disc... Can a simulated cell hold the key to sky-high attrition rates between cancer drug discovery and approval?
News Regeneron's three-monthly gMG drug Livsayis cleared by FDA Regeneron has joined the crowded gMG market with an siRNA-based therapy, Livsayis, that only needs to be dosed four times a year.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.